fasudil has been researched along with Coxsackie Virus Infections in 1 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate whether there exists a cardio-protective effect of Fasudil, a selective Rho kinase (ROCK) inhibitor, in an experimental murine model of acute viral myocarditis." | 7.88 | Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis. ( Chen, Q; Dai, K; Kuver, A; Li, J; Lian, H; Liao, W; Ni, H; Tai, S; Wang, Y; Yu, Y; Zheng, C, 2018) |
| "To investigate whether there exists a cardio-protective effect of Fasudil, a selective Rho kinase (ROCK) inhibitor, in an experimental murine model of acute viral myocarditis." | 3.88 | Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis. ( Chen, Q; Dai, K; Kuver, A; Li, J; Lian, H; Liao, W; Ni, H; Tai, S; Wang, Y; Yu, Y; Zheng, C, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dai, K | 1 |
| Wang, Y | 1 |
| Tai, S | 1 |
| Ni, H | 1 |
| Lian, H | 1 |
| Yu, Y | 1 |
| Liao, W | 1 |
| Zheng, C | 1 |
| Chen, Q | 1 |
| Kuver, A | 1 |
| Li, J | 1 |
1 other study available for fasudil and Coxsackie Virus Infections
| Article | Year |
|---|---|
Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Anti-Inflammatory Agents; Antiviral Agents; | 2018 |